CoChat

Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology

Open access
Rahman, Md. Mominur, Bibi, Shabana, Rahaman, Md. Saidur, Rahman, Firoza, Islam, Fahadul, Khan, Muhammad Saad, Hasan, Mohammad Mehedi, Parvez, Anwar, Hossain, Md. Abid, Maeesa, Saila Kabir, Islam, Md. Rezaul, Najda, Agnieszka, Al-malky, Hamdan S., Mohamed, Hanan R.H., AlGwaiz, Hussah I.M., Awaji, Aeshah A., Germoush, Mousa O., Kensara, Osama A., Abdel-Daim, Mohamed M., Saeed, Mohd, Kamal, Mohammad Amjad · 2022 · Biomedicine & Pharmacotherapy
Cited by 166

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Lung diseases including chronic obstructive pulmonary disease (COPD), infections like influenza, acute respiratory distress syndrome (ARDS), asthma and pneumonia lung cancer (LC) are common causes of sickness and death worldwide due to their remoteness, cold and harsh climatic conditions, and inaccessible health care facilities. PURPOSE: Many drugs have already been proposed for the treatment of lung diseases. Few of them are in clinical trials and have the potential to cure infectious diseases. Plant extracts or herbal products have been extensively used as Traditional Chinese Medicine (TCM) and Indian Ayurveda. Moreover, it has been involved in the inhibition of certain genes/protiens effects to promote regulation of signaling pathways. Natural remedies have been scientifically proven with remarkable bioactivities and are considered a cheap and safe source for lung disease. METHODS: This comprehensive review highlighted the literature about traditional plants and their metabolites with their applications for the treatment of lung diseases through experimental models in humans. Natural drugs information and mode of mechanism have been studied through the literature retrieved by Google Scholar, ScienceDirect, SciFinder, Scopus and Medline PubMed resources against lung diseases. RESULTS: In vitro, in vivo and computational studies have been explained for natural metabolites derived from plants (like flavonoids, alkaloids, and terpenoids) against different types of lung diseases. Probiotics have also been biologically active therapeutics against cancer, anti-inflammation, antiplatelet, antiviral, and antioxidants associated with lung diseases. CONCLUSION: The results of the mentioned natural metabolites repurposed for different lung diseases especially for SARS-CoV-2 should be evaluated more by advance computational applications, experimental models in the biological system, also need to be validated by clinical trials so that we may be able to retrieve potential drugs for most challenging lung diseases especially SARS-CoV-2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2022.113041This paper is marked retracted.

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Metadata

Authors
Rahman, M. M., Bibi, S., Rahaman, M. S., Rahman, F., Islam, F., Khan, M. S., Hasan, M. M., Parvez, A., Hossain, M. A., Maeesa, S. K., Islam, M. R., Najda, A., Al-malky, H. S., Mohamed, H. R. H., AlGwaiz, H. I. M., Awaji, A. A., Germoush, M. O., Kensara, O. A., Abdel-Daim, M. M., Saeed, M., & Kamal, M. A.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2022-06
Volume
150
Pages
113041
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4229023655
Cited by
166
References
11
FWCI
19.25
Type
journal article
Language
en
Status
Retracted
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology. https://app.cochat.ai/papers/10.1016/j.biopha.2022.113041
The paper
Rahman, M. M., Bibi, S., Rahaman, M. S., Rahman, F., Islam, F., Khan, M. S., Hasan, M. M., Parvez, A., Hossain, M. A., Maeesa, S. K., Islam, M. R., Najda, A., Al-malky, H. S., Mohamed, H. R. H., AlGwaiz, H. I. M., Awaji, A. A., Germoush, M. O., Kensara, O. A., Abdel-Daim, M. M., . . . Kamal, M. A. (2022). Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2022.113041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.